The systemic absorption and disposition of levobupivacaine 0.5% after epidural administration in surgical patients: A stable-isotope study

European Journal of Anaesthesiology

Volumn 21, Issue 6, 2004, Pages 460-470

  Simon, Mischa J G ^a   Veering, B T ^a   Stienstra, R ^a   Van Kleef, J W ^a   Williams, S G P ^b   McGuire, G M ^b   Burm, A G L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Inveresk Research   (United Kingdom)

Author keywords

Anaesthetic techniques, epidural; Anaesthetics, local, levobupivacaine; Human experimentation; Pharmacokinetics, levobupivacaine

Indexed keywords

DEUTERIUM; ISOTOPE; LEVOBUPIVACAINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHEMICAL REACTION KINETICS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; STEADY STATE; VALIDATION PROCESS;

ADOLESCENT; ADULT; ANESTHESIA, EPIDURAL; BUPIVACAINE; DEUTERIUM; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 3042742657     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021504006088     Document Type: Article

References (31)

1. Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in sheep. Br J Anaesth 1991; 67: 239-246.
2. Mather LE, Rutten AJ, Plummer JL. Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design. J Pharmacokinet Biopharm 1994; 22: 481-498.
3. Burm AGL, Van der Meer AD, Van Kleef JW, Zeijlmans PWM, Groen K. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994; 38: 125-129.
4. Groen K, Mantel M, Zeijlmans PWM, et al. Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates. Anesth Analg 1998; 86: 361-366.
5. Lee-Son S, Wang GK, Concus A, Crill E, Strichartz G. Stereoselective inhibition of neuronal sodium channels by local anesthetics. Anesthesiology 1992; 77: 324-335.
6. Kanai Y, Katsuki H, Takasaki M. Comparisons of the anesthetic potency and intracellular concentrations of S(-) and R(+) bupivacaine and ropivacaine in crayfish giant axon in vitro. Anesth Analg 2000; 90: 415-420.
7. Vanhoutte F, Vereecke J, Verbeke N, Carmeliet E. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol 1991; 103: 1275-1281.
8. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992; 17: 311-316.
9. Mazoit JX, Decaux A, Bouaziz H, Edouard A. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levobupivacaine, and ropivacaine on the isolated rabbit heart. Anesthesiology 2000; 93: 784-792.
10. Thomas JM, Schug SA. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions. Clin Pharmacokinet 1999; 36: 67-83.
11. Gennery B, Mather LE, Strichartz G. Levobupivacaine: new preclinical and clinical data. Semin Anesth 2000; 19: 132-148.
12. Burm AGL, Vermeulen NPE, Van Kleef JW, De Boer AG, Spierdijk J, Breimer DD. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes. Clin Pharmacokinet 1987; 13: 191-203.
13. Burm AGL, De Boer AG, Van Kleef JW, et al. Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: a study in healthy volunteers. Biopharm Drug Dispos 1988; 9: 85-95.
14. Bader AM, Tsen LC, Camann WR, Nephew E, Datta S. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999; 90: 1596-1601.
15. Kopacz DJ, Allen HW, Thompson GE. A comparison of epidural levobupivacaine 0.75% with racemic bupivacaine for lower abdominal surgery. Anesth Analg 2000; 90: 642-648.
16. Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 1980; 8: 509-534.
17. Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 1979; 68: 1071-1074.
18. Perrier D, Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci 1982; 71: 372-373.
19. Iga K, Ogawa Y, Yashiki T, Shimamoto T. Estimation of drug absorption rates using a deconvolution method with nonequal sampling times. J Pharmacokinet Biopharm 1986; 14: 213-225.
20. Veering BT, Burm AGL, Vletter AA, Van den Heuvel RPM, Onkenhout W, Spierdijk J. The effect of age on the systemic absorption, disposition and pharmacodynamics of bupivacaine after epidural administration. Clin Pharmacokinet 1992; 22: 75-84.
21. Pabst G, Jaeger H. Review of methods and criteria for the evaluation of bioequivalence studies. Eur J Clin Pharmacol 1990; 38: 5-10.
22. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987; 15: 657-680.
23. McClellan KJ, Spencer CM. Levobupivacaine. Drugs 1998; 56: 355-362.
24. Gristwood RW, Greaves JL. Levobupivacaine: a new safer long acting local anaesthetic agent. Expert Opin Invest Drug 1999; 8: 861-876.
25. Tucker GT, Mather LE. Pharmacology of local anaesthetic agents. Pharmacokinetics of local anaesthetic agents. Br J Anaesth 1975; 47: 213-224.
26. Emanuelsson BM, Persson J, Alm C, Heller A, Gustafsson LL. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology 1997; 87: 1309-1317.
27. Aps C, Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol 1978; 6: 63-68.
28. Khodorova AB, Strichartz GR. The addition of dilute epinephrine produces equieffectiveness of bupivacaine enantiomers for cutaneous analgesia in the rat. Anesth Analg 2000; 91: 410-416.
29. Newton DJ, Burke D, Khan F, et al. Skin blood flow changes in response to intradermal injection of bupivacaine and levobupivacaine, assessed by laser Doppler imaging. Reg Anesth Pain Med 2000; 25: 626-631.
30. Bader AM, Tsen LC, Camann WR, Nephew E, Datta S. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999; 90: 1596-1601.
31. Cox CR, Faccenda KA, Gilhooly C, Bannister J, Scott NB, Morrison LM. Extradural S(-)-bupivacaine: comparison with racemic RS-bupivacaine. Br J Anaesth 1998; 80: 289-293.